Immutol awards Acton list management
Immunocorp turned over management of its inquirers list for Immutol, an immune system supplement, to Acton May 6. The file is new to the market.
The prospect file is about evenly split between males and females. It contains data for consumers who have responded to a direct media offer for a free sample of the product.
The 7,643-universe list is available beginning at $150/M.